HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Tzu-Chen Lin Selected Research

Carcinoembryonic Antigen

7/2015Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
10/2014The role of adjuvant chemotherapy in stage II colorectal cancer patients.
7/2014Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.
6/2014The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer Patients.
8/2013The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients.
1/2013Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
10/2012Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
5/2012Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normal.
9/2011Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer.
5/2007p53 protein accumulation as a prognostic marker in sporadic colorectal cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Tzu-Chen Lin Research Topics

Disease

31Colorectal Neoplasms (Colorectal Cancer)
07/2015 - 01/2002
18Neoplasms (Cancer)
07/2015 - 01/2002
7Neoplasm Metastasis (Metastasis)
10/2013 - 01/2002
6Rectal Neoplasms (Rectal Cancer)
07/2015 - 01/2002
5Colonic Neoplasms (Colon Cancer)
09/2014 - 06/2009
3Microsatellite Instability
09/2014 - 02/2005
2Peripheral Nervous System Diseases (PNS Diseases)
07/2012 - 03/2007
1Human Influenza (Influenza)
06/2014
1Sarcoma (Soft Tissue Sarcoma)
08/2012
1Pain (Aches)
07/2012
1Neuralgia (Stump Neuralgia)
07/2012
1Pruritus (Itching)
01/2012
1Liver Abscess
10/2011
1Pneumothorax
02/2011
1Necrosis
02/2011
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
10/2010
1Xeroderma Pigmentosum (Kaposi's Disease)
07/2009
1Fever (Fevers)
05/2008
1Diarrhea
05/2008
1Neutropenia
05/2008
1Disease Progression
04/2005
1Aneuploidy (Aneuploid)
11/2003
1Adenocarcinoma
11/2003
1Peritonitis
10/2003
1Foreign Bodies (Foreign Body)
10/2003
1Sepsis (Septicemia)
10/2003

Drug/Important Bio-Agent (IBA)

14Carcinoembryonic AntigenIBA
07/2015 - 01/2002
9oxaliplatin (Eloxatin)FDA LinkGeneric
11/2014 - 03/2007
6Codon (Codons)IBA
10/2014 - 09/2006
5Fluorouracil (Carac)FDA LinkGeneric
05/2012 - 06/2007
4Epidermal Growth Factor Receptor (EGF Receptor)IBA
06/2015 - 06/2007
4irinotecan (Camptosar)FDA LinkGeneric
11/2014 - 05/2008
4Leucovorin (Folinic Acid)FDA Link
09/2011 - 03/2002
3N-methylsuccinimideIBA
09/2014 - 02/2005
3AntigensIBA
10/2012 - 01/2002
3MucinsIBA
03/2012 - 09/2006
3DNA (Deoxyribonucleic Acid)IBA
07/2009 - 11/2003
2Calcibiotic Root Canal SealerIBA
03/2015 - 09/2006
2bevacizumabFDA Link
11/2014 - 02/2011
2TegafurIBA
03/2005 - 03/2002
2UracilIBA
03/2005 - 03/2002
1Carbon MonoxideIBA
07/2015
1cetuximab (Erbitux)FDA Link
11/2014
1tamiphosphorIBA
06/2014
1Neuraminidase (Sialidase)IBA
06/2014
1Oseltamivir (Tamiflu)FDA Link
06/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2014
1celecoxib (Celebrex)FDA Link
05/2014
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
10/2012
1duloxetine (Cymbalta)FDA Link
07/2012
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
05/2012
1N 30IBA
01/2012
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2010
1Insulin (Novolin)FDA Link
10/2010
1PlatinumIBA
07/2009
1BilirubinIBA
05/2008
1Glutamine (L-Glutamine)FDA Link
03/2007
1Folic Acid (Vitamin M)FDA LinkGeneric
09/2006
1von Willebrand FactorIBA
04/2005
1Biological Markers (Surrogate Marker)IBA
04/2005
1Biological Tumor Markers (Tumor Markers)IBA
04/2005
1AntibodiesIBA
01/2005
1Radioisotopes (Radionuclides)IBA
01/2004
1A-factor (Streptomyces)IBA
01/2002

Therapy/Procedure

12Drug Therapy (Chemotherapy)
07/2015 - 01/2002
3Adjuvant Chemotherapy
10/2014 - 06/2009
2Radiotherapy
05/2014 - 03/2005
1Thoracostomy
02/2011
1Catheters
02/2011
1Laparotomy
10/2003
1Anesthesia
10/2003
1Colonic Pouches (S Pouch)
01/2002